Related Experiment Videos
Pleural fluids associated with chest infection
1Department of Paediatrics, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.
Insights
Pediatric empyema, a complication of pneumonia, requires prompt recognition and treatment. Intrapleural fibrinolytic therapy can improve outcomes by reducing hospital stays and surgical needs.
Area of Science:
- Pediatric Pulmonology
- Thoracic Surgery
- Infectious Diseases
Background:
- Pleural effusions frequently accompany pneumonias, with a subset progressing to empyema.
- Optimal management strategies for pediatric empyema are debated, highlighting the need for effective interventions.
- Early diagnosis and treatment are crucial to prevent increased morbidity associated with delayed therapy.
Purpose of the Study:
- To review the pathophysiology of pleural fluid in the context of empyema.
- To discuss the current therapeutic approaches for pediatric empyema.
- To evaluate the role and efficacy of intrapleural fibrinolytic therapy.
Main Methods:
- Review of current literature on pediatric empyema management.
- Analysis of the pathophysiology of pleural fluid dynamics.
- Evaluation of treatment outcomes, including hospital stay and surgical intervention rates.
Main Results:
- Conventional treatment with antibiotics and chest tubes may be insufficient for viscous or loculated effusions.
- Intrapleural fibrinolytic therapy demonstrates potential to shorten hospital stays and decrease surgical intervention necessity.
- The long-term prognosis for children with parapneumonic empyema is generally excellent, with preserved lung function.
Conclusions:
- Prompt recognition and management of pediatric empyema are vital for optimal outcomes.
- Intrapleural fibrinolytic therapy offers a promising adjunct or alternative to conventional management in select cases.
- Most children with parapneumonic empyema achieve full recovery and maintain normal lung function post-treatment.
Abstract:
Pleural effusions are commonly associated with pneumonias and a small number of these progress to empyema. An understanding of the physiology and pathophysiology of pleural fluid aids the clinician in the management of empyema. There remains much debate about the optimal treatment of empyema in children. Early recognition of the condition is important since delayed therapy may result in unnecessary morbidity. Conventional management with high dose parenteral antibiotics and chest tube drainage remains the mainstay of therapy. However, this treatment modality may fail if the pleural fluid becomes viscous and loculated and, therefore, a more aggressive approach is required. Intrapleural fibrinolytic therapy has been shown to decrease the length of hospital stay and may reduce the need for surgical intervention. The prognosis in children with parapneumonic empyema is excellent with the vast majority retaining normal lung function at long term follow-up.